Borres, Rayver .

HRN: 22-61-96  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/13/2023
AMPICILLIN 250MG (VIAL)
02/13/2023
02/19/2023
IV
250mg
Q6hr
PCAP-C
Waiting Final Action 
02/13/2023
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
02/13/2023
02/20/2023
IV
150mg
Q24hrs
PCAP
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: